Early Phase Pre-Clinical and Initial Clinical Research on Epicatechin (Part 2)

Completed · Phase 1 · Has a placebo group

Conditions studied: Pre-diabetes

In brief

This will be a double-blind, randomized, placebo-controlled, single dose study of (+)- epicatechin with one 30mg dose/day for a total of 7 days

Key facts

Study ID
NCT02656212
Run by
Veterans Medical Research Foundation
People needed
15
Starts
2015-09-01
Expected to finish
2016-04-01
Last updated by the study team
2016-04-28

Who can join

Age: 21 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.